PAA 2.50% 20.5¢ pharmaust limited

Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity, page-418

  1. 12,209 Posts.
    lightbulb Created with Sketch. 6223
    From the 4c statement surrounding MPL vs Cov I actually believe we could be ahead of the schedule , if PAA are in communications with trialing clinics and they have stated they have written an Executive Summary to facilitate a PhaseI Covid Human Trial
    you have only need 1 clinic in a lower regulated environment to say “yes” ,, they won’t need 10kgs , in fact Epichem could press an R and D batch of pills or possibly utilise those in storage for stability testing??

    also Leiden confirm in that report “there are indications of antiviral activity in the essays “ and that was with poor solubility that they have now overcome

    IMHO Leiden data will only confirm the first 3 positive trial outcomes but feel sure when Leiden say something “people” listen and act ,
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.